Osiris Therapeutics (OSIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Sales | 23,688 | 21,003 | 19,319 | 17,204 | 13,290 |
| Cost of Goods | 5,142 | 4,609 | 4,250 | 3,785 | 2,924 |
| Gross Profit | 18,546 | 16,394 | 15,069 | 13,419 | 10,366 |
| Operating Expenses | 16,955 | 15,160 | 14,139 | 12,985 | 11,356 |
| Operating Income | 1,733 | 1,843 | 1,180 | 1,219 | -66 |
| Other Income | -202 | 146 | -8 | -405 | -1,232 |
| Pre-tax Income | 1,531 | 1,989 | 1,172 | 814 | -1,298 |
| Income Tax | 367 | 612 | 89 | 104 | 130 |
| Net Income Continuous | 1,164 | 1,377 | 1,083 | 710 | -1,428 |
| Net Income Discontinuous | N/A | N/A | -267 | -65 | -457 |
| Net Income | $1,164 | $1,377 | $816 | $645 | $-1,885 |
| EPS Basic Total Ops | 0.03 | 0.04 | 0.02 | 0.02 | -0.05 |
| EPS Basic Continuous Ops | 0.03 | 0.04 | 0.03 | 0.02 | -0.04 |
| EPS Basic Discontinuous Ops | N/A | N/A | -0.01 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.03 | 0.04 | 0.02 | 0.02 | -0.05 |
| EPS Diluted Continuous Ops | 0.03 | 0.04 | 0.03 | 0.02 | -0.04 |
| EPS Diluted Discontinuous Ops | N/A | N/A | -0.01 | 0.00 | -0.01 |
| EBITDA(a) | $2,013 | $2,110 | $1,435 | $1,463 | $161 |